In the context of osteosarcoma, however, it is currently unknown whether GnRH or kisspeptin alter the function of the RANK-RANKL-OPG system, change NF-κB activation, or experience regulation of expression and secretion via NF-κB. Here, NFKB1 is linked to osteosarcoma.